About Konniseri Pharmaceuticals Private Limited
Data last updated:
Konniseri Pharmaceuticals Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 06 February 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24239KA2017PTC099699. The company has 2 GST registrations on record, none of which is active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Shankar Usha and Nalini.
Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at Sy No.111 Rm No.1 Sri Adithya Arcade 2nd Floor Kundalahalli, Bangalore, Karnataka, India – 560037.
As per the financials filed for FY 2019, the company reported a revenue of ₹13.07 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹26.28 Lakh (net margin -201.1%) and EBITDA of -₹25.04 Lakh (EBITDA margin -191.6%).
The company has about 11 employees on its provident fund (EPFO) records.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website konniseri.com.
Company details
Contact details
Konniseri Pharmaceuticals Private Limited's registered office is in Bangalore, Karnataka. Its website is konniseri.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressSy No.111 Rm No.1 Sri Adithya Arcade 2nd Floor Kundalahalli, Bangalore, Karnataka, India – 560037
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Konniseri Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Konniseri Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Konniseri Pharmaceuticals Private Limited, buy the company report.
Financials of Konniseri Pharmaceuticals Private Limited
FY 2019 filings availableKonniseri Pharmaceuticals Private Limited reported revenue of ₹13.07 Lakh (up 1041% YoY) for FY 2019.
Financial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | ₹13.07 Lakh | ||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹25.04 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹26.28 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -191.6% | ||
| Net Profit Margin | -201.1% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Konniseri Pharmaceuticals Private Limited, buy the company report.
Board of directors of Konniseri Pharmaceuticals Private Limited
Konniseri Pharmaceuticals has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shankar Usha | Additional Director | 15 Apr 2025 | 1 Years 6 Months | Current |
| Nalini | Additional Director | 04 Mar 2026 | 0 Years 7 Months | Current |
Peer comparison
Konniseri Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Delmas Pharmaceuticals Private Limited | ₹13.12 Lakh (FY 2024) | 13.0% | Jaipur, Rajasthan, India | |||
| Gynus Pharmaceuticals Private Limited | ₹13.1 Lakh (FY 2025) | 0.0% | Allahabad, Uttar Pradesh, India | |||
| Konniseri Pharmaceuticals Private Limitedthis company | ₹13.07 Lakh (FY 2019) | -₹26.28 Lakh | -201.1% | 1041.0% | Bangalore, Karnataka, India | |
| Doctors Pharmaceuticals Private Limited | ₹13.03 Lakh (FY 2025) | -14.0% | Unnao, Uttar Pradesh, India |
To see the full peer comparison of Konniseri Pharmaceuticals Private Limited, buy the company report.
Auditor
Konniseri Pharmaceuticals Private Limited is audited by P P K G & CO for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| P P K G & CO | FY 2019 | 009655S |
Shareholding
The shareholding of Konniseri Pharmaceuticals Private Limited is on record for FY 2019, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2019 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Konniseri Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Konniseri Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Konniseri Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Konniseri Pharmaceuticals has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Konniseri Pharmaceuticals Private Limited, buy the company report.
Recent activity
Konniseri Pharmaceuticals Private Limited has 7 board changes on record since 2018: 3 appointments and 4 cessations. The latest: Nalini was appointed as Additional Director on 04 Mar 2026.
Frequently asked questions
Konniseri Pharmaceuticals is an active private limited company based in Bangalore, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 06 February 2017 (9+ years old) and is registered under CIN U24239KA2017PTC099699.
Konniseri Pharmaceuticals has 2 current directors:
- Shankar Usha - Additional Director
- Nalini - Additional Director
The latest financial statements of Konniseri Pharmaceuticals on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 30 September 2019. Year-wise statements from FY 2017 are in the company report.
No. Konniseri Pharmaceuticals has 2 GST registrations on record and all of them are cancelled or inactive.
The CIN (Corporate Identification Number) of Konniseri Pharmaceuticals is U24239KA2017PTC099699. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Konniseri Pharmaceuticals was incorporated on 06 February 2017, making it 9+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Konniseri Pharmaceuticals by revenue are Delmas Pharmaceuticals Private Limited, Gynus Pharmaceuticals Private Limited, Doctors Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Nalini was appointed as Additional Director on 04 Mar 2026. Krishnan Akhilesh Narayan ceased to be Director on 16 Apr 2025. Shankar Usha was appointed as Additional Director on 15 Apr 2025. Konniseri Pharmaceuticals has 7 board changes on record in total.
Konniseri Pharmaceuticals can be reached through the website konniseri.com. Its registered office is in Bangalore, Karnataka, India.
The registered office of Konniseri Pharmaceuticals is at Sy No.111 Rm No.1 Sri Adithya Arcade 2nd Floor Kundalahalli, Bangalore, Karnataka, India – 560037.
Konniseri Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.